GT Biopharma, Inc.(NasdaqCM:GTBP) dropped from Russell 3000E Index
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.325 USD | +2.99% | +4.07% | -56.54% |
03-26 | GT Biopharma, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
02-01 | GT Biopharma to Conduct 1-for-30 Reverse Stock Split; Shares Fall | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-56.54% | 4.46M | |
+30.38% | 695B | |
+26.51% | 568B | |
-4.36% | 361B | |
+19.30% | 330B | |
+3.73% | 283B | |
+16.70% | 239B | |
+8.78% | 204B | |
-7.93% | 198B | |
+7.68% | 168B |
- Stock Market
- Equities
- GTBP Stock
- News GT Biopharma, Inc.
- GT Biopharma, Inc.(NasdaqCM: GTBP) dropped from Russell 3000E Index